Edition:
United Kingdom

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Capital Market

0.63USD
15 Jan 2019
Change (% chg)

$0.02 (+3.97%)
Prev Close
$0.61
Open
$0.61
Day's High
$0.64
Day's Low
$0.59
Volume
58,577
Avg. Vol
64,358
52-wk High
$1.25
52-wk Low
$0.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.090
Jun '18 0.00 -0.052
Mar '18 0.00 -0.223
FY 2017 Dec '17 0.00 -0.374
Sep '17 0.00 -0.588
Jun '17 0.00 -0.539
Mar '17 0.00 -0.482
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Quarter Ending Jun-19 2 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 2 -0.12 -0.10 -0.13 --
Quarter Ending Jun-19 2 -0.12 -0.10 -0.13 --
Year Ending Dec-19 4 -0.56 -0.40 -0.82 -1.58
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.38
P/E High - Last 5 Yrs. -- 148.01 46.19
P/E Low - Last 5 Yrs. -- 47.79 24.58
Beta 2.01 1.08 0.91
Price to Sales (TTM) -- 49.51 6.26
Price to Book (MRQ) 2.61 10.16 5.20
Price to Tangible Book (MRQ) 2.61 13.82 6.73
Price to Cash Flow (TTM) -- 52.80 24.17
% Owned Institutions 64.82 3.75 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.93
Payout Ratio(TTM) -- 7.04 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.91 8.17
Sales (TTM) vs TTM 1 Yr. Ago -100.00 47.85 6.48
Sales - 5 Yr. Growth Rate -33.60 22.76 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -38.18 75.87 23.23
EPS (TTM) vs TTM 1 Yr. Ago -38.48 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate 51.50 9.25 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.30
Current Ratio (MRQ) 2.96 3.43 3.12
LT Debt to Equity (MRQ) 56.20 18.73 11.47
Total Debt to Equity (MRQ) 89.62 31.43 16.03
Interest Coverage (TTM) -34.13 -43.27 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 54.45
Gross Margin - 5 Yr. Avg. -- 60.55 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,867.76 -110.00 13.10
Operating Margin (TTM) -- -184.40 6.05
Operating Margin - 5 Yr. Avg. -3,985.97 -126.43 8.39
Pre-Tax Margin (TTM) -- -175.18 7.01
Pre-Tax Margin - 5 Yr. Avg. -4,119.48 -132.58 8.67
Net Profit Margin (TTM) -- -181.91 3.11
Net Profit Margin - 5 Yr. Avg. -4,119.48 -136.98 4.86
Effective Tax Rate (TTM) -- 21.48 23.27
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,650,987 873,304,761
Net Income/Employee (TTM) -590,908 652,634 103,509,273
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.57
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.49 6.45 11.45
Return on Assets - 5 Yr. Avg. -70.17 5.52 12.50
Return on Investment (TTM) -97.45 8.99 14.96
Return on Investment - 5 Yr. Avg. -79.43 6.86 16.23
Return on Equity (TTM) -127.17 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.36
  1 Year 3 Year 5 Year
Sales % -64.93 -31.50 -33.60
EPS (TTM) % -0.86 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Genocea Biosciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.49%
# of Holders: 55
Total Shares Held: 49,803,254
3 Mo. Net Change: -2,000
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.